| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/05/2009 | CN100522231C Externally-applied bone-set plaster and its production |
| 08/05/2009 | CN100522230C Medicine for treating diabetes and hephrosis and its preparing method |
| 08/05/2009 | CN100522225C Preparation of compound mixture and its inspection |
| 08/05/2009 | CN100522224C Medicine for treating rhinitis and method for preparing the same |
| 08/05/2009 | CN100522220C Oral medicine for treating breast cancer |
| 08/05/2009 | CN100522217C Tablets made of hedgehog hydnum for stomach-health and its preparation process |
| 08/05/2009 | CN100522216C Medicine for treating traumatic injury |
| 08/05/2009 | CN100522215C Traditional Chinese medicine composition for treating traumatic injury and bone fracture |
| 08/05/2009 | CN100522202C Preparation containing lyophilized powder of deer fetus, its preparation method and use |
| 08/05/2009 | CN100522197C Chinese-medicinal preparation for treating high blood fat and its making method |
| 08/05/2009 | CN100522186C Sustained release capsules of ginkgo leaf and preparation method |
| 08/05/2009 | CN100522183C Earthworm acidic-part medicine for treating cough asthma disease and preparing method |
| 08/05/2009 | CN100522143C Gynaecologic leucorrhea removing granules preparation and preparing process thereof |
| 08/04/2009 | US7569538 Vaccines against cancer of the upper respiratory tract or anogenital carcinomas, such as cervical cancer, using fragments of the cyclin-dependent kinase inhibitor P16 protein |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569383 Chimeric flavivirus vectors |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | US7569218 Compositions for and methods of using herpes simplex virus glycoprotein D to suppress immune responses |
| 08/04/2009 | CA2331772C Hemoglobins to maintain cell energy status |
| 08/04/2009 | CA2222323C Vascularized tissue regeneration matrices formed by solid free-form fabrication methods |
| 07/30/2009 | WO2009094400A2 Pancreatic islet cell preparation and transplantation |
| 07/30/2009 | WO2009094340A2 Omentum and use thereof |
| 07/30/2009 | WO2009093928A1 Agent for leg care against in case of chronic venous insufficiency of lower extremities |
| 07/30/2009 | WO2009093900A1 Mid-log phase lactic acid bacteria for inducing immune tolerance in a subject |
| 07/30/2009 | WO2009093605A1 Anti-canine periodontal disease composition |
| 07/30/2009 | WO2009093447A1 Anti-tumor agent for gastrointestinal cancer |
| 07/30/2009 | WO2009093408A1 Methods for gene transfer to mammals |
| 07/30/2009 | WO2009092810A2 Single pharmaceutical composition containing antibiotics and probiotics |
| 07/30/2009 | WO2009092628A1 Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule |
| 07/30/2009 | WO2009092383A2 Products and methods to prevent infection |
| 07/30/2009 | WO2009006600A9 Density gradient isolation of pancreatic islet cells |
| 07/30/2009 | WO2008141523A8 A strain capable of producing arginine deiminase and the use thereof |
| 07/30/2009 | WO2008054825A8 Mixed cell populations for tissue repair and separation technique for cell processing |
| 07/30/2009 | US20090192474 Delivery system |
| 07/30/2009 | US20090191278 Homeopathy-based formulation |
| 07/30/2009 | US20090191269 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition |
| 07/30/2009 | US20090191254 Inhibition of biofilm formation using bacteriophage |
| 07/30/2009 | US20090191243 High unsaponifiables and methods of using the same and its derivatives and uses thereof |
| 07/30/2009 | US20090191242 Novel homeopathic strain comprising a nosode from a protozoon of the genus trypanosoma |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191194 Inhibition of protein kinase c alpha for the treatment of cardiovascular diseases |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191178 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 07/30/2009 | US20090191175 Therapeutic methods using peg-conjugated agents and devices for performing the same |
| 07/30/2009 | US20090191174 Blood processing device and associated systems and methods |
| 07/30/2009 | US20090191172 Method of Controlling Administration of Cancer Antigen |
| 07/30/2009 | US20090191171 Reprogramming of Differentiated Progenitor or Somatic Cells Using Homologous Recombination |
| 07/30/2009 | US20090191169 Methods for gene transfer to mammals |
| 07/30/2009 | US20090191168 Pregnancy-Induced Oligodendrocyte Precursor Cell Proliferation Regulated by Prolactin |
| 07/30/2009 | US20090191167 Adult sertoli cells and uses thereof |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191165 Fibrin glue composition for repairing nerve damage and methods thereof |
| 07/30/2009 | US20090191164 Human hematopoietic multipotent progenitor cells |
| 07/30/2009 | US20090191162 Catecholamine Receptor Modulation |
| 07/30/2009 | US20090191161 Tenocyte cell culturing method |
| 07/30/2009 | US20090191160 Methods of producing pluripotent stem-like cells |
| 07/30/2009 | US20090191158 Defective interfering virus |
| 07/30/2009 | US20090191157 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
| 07/30/2009 | US20090191156 Gm-csf cosmeceutical compositions and methods of use thereof |
| 07/30/2009 | US20090191155 Usher 1B syndrome ocular disease; delivering subretinally to target cells; expression vehicle is HIV-1; CMV-MYO7A promoter or promoter active in photoreceptor or retinal pigment epithelium (RPE) cell; polynucleotide sequence encoding myosin VIIA; chromosomal integration sequence; gene therapy; blindness |
| 07/30/2009 | US20090191127 Omentum and use thereof |
| 07/30/2009 | CA2712745A1 Pancreatic islet cell preparation and transplantation |
| 07/30/2009 | CA2712207A1 Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule |
| 07/29/2009 | EP2083076A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 07/29/2009 | EP2082745A1 Method for cancer therapy with a parvovirus combined with chemotherapy |
| 07/29/2009 | EP2082731A1 Use of a combination of hesperidin and a micro-organism to act on the barrier function of the skin |
| 07/29/2009 | EP2082723A1 Topical anti-microbial compositions |
| 07/29/2009 | EP2081579A2 Food supplement agent based on rock |
| 07/29/2009 | EP2081566A1 Improved biological effects of compositions comprising rosmarinic acid |
| 07/29/2009 | EP1993515B1 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
| 07/29/2009 | EP1636348B1 Method of generating islet beta-cells from exocrine pancreatic cells |
| 07/29/2009 | EP1389043B1 Foot and mouth disease virus vaccine |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1036327B1 HLA-E binding to CD94/NKG2+ cells |
| 07/29/2009 | EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 07/29/2009 | CN101495126A Use of mutant herpes simplex virus-2 for cancer therapy |
| 07/29/2009 | CN101491670A Method for treating cardiovascular disease using nervous regulation protein and composite |
| 07/29/2009 | CN101491545A Method for extracting polysaccharide and nucleic acid from bacill calmette-guerin |
| 07/29/2009 | CN101491544A Method for extracting silkworm faeces total alkaloid in silkworm faeces extraction solution |
| 07/29/2009 | CN101491543A Use of sea collagen peptide in preparing medicine or food capable of improving senility memory function |
| 07/29/2009 | CN101491542A Selenium-rich toad shell superfines with cancer prevention anti-cancer function |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/28/2009 | US7566570 Method for the separation of phospholipids from phospholipid-containing materials |
| 07/28/2009 | US7566568 Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
| 07/28/2009 | CA2617465A1 Triple spin, double pool and revolumization process for concentrating platelets, and derivative platelet concentrate |
| 07/28/2009 | CA2435159C A method of preparing a collagen sponge |
| 07/23/2009 | WO2009091050A1 Composition for oral application |
| 07/23/2009 | WO2009090970A1 Liver function-protecting agent |
| 07/23/2009 | WO2009090961A1 Agent for prevention of alcoholic hepatopathy |
| 07/23/2009 | WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 07/23/2009 | WO2009090655A2 Colloidal collagen burn wound dressing produced from jellyfish |
| 07/23/2009 | WO2009090190A1 Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene |
| 07/23/2009 | WO2009090093A1 Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation |
| 07/23/2009 | WO2009089889A1 Use of isothiocyanate derivatives as anti-myeloma agents |
| 07/23/2009 | WO2009089568A1 Immunomodulating compositions and uses therefor |
| 07/23/2009 | WO2009061221A3 Agent stabilisation process and product |
| 07/23/2009 | WO2009055001A3 Methods of treating aging and methods of screening candidate agents therefor |
| 07/23/2009 | WO2009048595A9 Herbal combination omega oil aphrodisiac |
| 07/23/2009 | WO2009045360A3 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |